-+ 0.00%
-+ 0.00%
-+ 0.00%

Incannex to launch DReAMzz Phase 2 crossover dose-optimization trial for IHL-42X in obstructive sleep apnea

Reuters·03/12/2026 12:06:21

Please log in to view news